Story perspectives

CIBC Tops App Satisfaction; TSX Rises on Inflation Boost

6/12/2025

24 6

Summary

Story summary

CIBC ranks highest in app satisfaction among Canadian banks, achieving 641 points despite varied earnings.
Canada's S&P/TSX index increased by 0.5%, driven by favorable U.S. inflation data and robust Dollarama performance.
Calian Group anticipates growth from rising Canadian defense spending, projected to reach $62.7 billion by 2025-26.
Analysts issued a "buy" rating for Stingray Group following strong quarterly results.
NervGen Pharma's spinal cord injury drug shows significant promise, with a potential market value over $30 billion.

1 of 1

Story summary

CIBC ranks highest in app satisfaction among Canadian banks, achieving 641 points despite varied earnings.
Canada's S&P/TSX index increased by 0.5%, driven by favorable U.S. inflation data and robust Dollarama performance.
Calian Group anticipates growth from rising Canadian defense spending, projected to reach $62.7 billion by 2025-26.
Analysts issued a "buy" rating for Stingray Group following strong quarterly results.
NervGen Pharma's spinal cord injury drug shows significant promise, with a potential market value over $30 billion.